BCAX Competitors & Alternatives
Compare Bicara Therapeutics Inc. Common Stock with similar stocks in the same industry
Biotechnology
BCAX
Main Stock$25.74
Tradestie Score
58
Market Cap
$906.29M
Analyst Upside
+22.2%
Top Competitors
228 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
OCUL
Ocular Therapeutix, Inc.
|
$8.40
|
$1.92B | - | 58 | Compare |
|
CELC
Celcuity Inc. Common Stock
|
$87.72
|
$1.92B | - | 45 | Compare |
|
LQDA
Liquidia Corporation Common Stock
|
$83.85
|
$1.90B | 494.8 | 56 | Compare |
|
VERA
Vera Therapeutics, Inc. Class A Common Stock
|
$32.23
|
$1.84B | - | 47 | Compare |
|
IMCR
Immunocore Holdings plc American Depositary Shares
|
$32.43
|
$1.81B | - | 51 | Compare |
|
ABCL
AbCellera Biologics Inc. Common Shares
|
$5.83
|
$1.78B | - | 55 | Compare |
|
DYN
Dyne Therapeutics, Inc. Common Stock
|
$25.24
|
$1.78B | - | 55 | Compare |
|
VRDN
Viridian Therapeutics, Inc. Common Stock
|
$19.31
|
$1.74B | - | 56 | Compare |
|
CLDX
Celldex Therapeutics, Inc
|
$37.69
|
$1.68B | - | 57 | Compare |
|
MNKD
Mannkind Corporation
|
$3.80
|
$1.65B | - | 51 | Compare |
More BCAX Analysis
Data updated: Aug 04, 2026 | Industry: Biotechnology (SIC 2834)
228 stocks in this industry